(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

TOMORROW IS GROWN HERE

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

TOMORROW IS GROWN HERE

ST13

US500000088064087

Class

5, 35, 40, 42

Filing

88064087

Registration

6367148

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

44

Latest update

06/02/2026

Trademark type

Word

Nice classes

5, 35, 40, 42

Filing date

08/03/2018

Registration date

06/01/2021

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

06/01/2021

Last transaction

06/02/2026

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Intent to use, Foreign priority

Drawing code

4

Owner type

03

Owner location

Québec (Québec), CA

Examiner

MESSICK, TABITHA LEE

Law office

L40

Current location

TMEG LAW OFFICE 104

Holders and representatives

Holders

Medicago Inc.

Representatives

Michelle P. Ciotola CANTOR COLBURN LLP

Technical classification

Nice Classes

Class 5Class 35Class 40Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Pharmaceutical and medicinal preparations and substanceshuman vaccinestherapeutic proteins and antibodies for the treatment of infectious diseaseschronic diseases and cancer

Class 35

Wholesale storeretail storeonline retail store services featuring pharmaceuticalspharmaceutical ingredientsvaccinestherapeutic proteins and antibodies

Class 40

Manufacture of pharmaceuticalspharmaceutical ingredientsvaccinestherapeutic proteins and antibodies for others; Custom manufacturing of pharmaceuticalspharmaceutical ingredientsvaccinestherapeutic proteins and antibodies

Class 42

Research and development in the field of vaccinesrecombinant proteins and antibodies for therapeutic and prophylactic use; high-throughput vaccine engineering services; medical and scientific research services of proprietary recombinant protein platform technologies designed to lead to new human vaccinestherapeutic proteins and antibodies; product research and development and scientific researchall in the field of protein production using recombinant technologies through transient expression in plants; medical and scientific research services relating to infectious diseases; development of new products for others in the field of pharmaceuticalspharmaceutical ingredientsvaccinestherapeutic proteins and antibodies; medical and scientific research regarding clinical trial studies on new vaccine candidates

Publications

History of USPTO decisions and trademark events.

44 publications found

REM1

COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED

06/01/2026

CHAN

APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED

05/04/2023

TCCA

TEAS CHANGE OF CORRESPONDENCE RECEIVED

05/04/2023

EWAF

TEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS

05/04/2023

ARAA

ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED

05/04/2023

REAP

TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED

05/04/2023

COAR

TEAS CHANGE OF OWNER ADDRESS RECEIVED

05/04/2023

COC.

CORRECTION UNDER SECTION 7 - PROCESSED

04/30/2022

APRE

CASE ASSIGNED TO POST REGISTRATION PARALEGAL

04/27/2022

ES7R

TEAS SECTION 7 REQUEST RECEIVED

12/03/2021

R.PR

REGISTERED-PRINCIPAL REGISTER

06/01/2021

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

03/16/2021

PUBO

PUBLISHED FOR OPPOSITION

03/16/2021

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

02/24/2021

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

02/05/2021

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/02/2021

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/02/2021

ALIE

ASSIGNED TO LIE

02/02/2021

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

01/22/2021

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

08/21/2020

GNSI

INQUIRY TO SUSPENSION E-MAILED

08/21/2020

CNSI

SUSPENSION INQUIRY WRITTEN

08/21/2020

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

02/21/2020

GNSL

LETTER OF SUSPENSION E-MAILED

02/21/2020

CNSL

SUSPENSION LETTER WRITTEN

02/21/2020

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/18/2020

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/18/2020

ALIE

ASSIGNED TO LIE

02/14/2020

ERSI

TEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED

02/11/2020

GNS2

NOTIFICATION OF INQUIRY AS TO SUSPENSION E-MAILED

09/05/2019

GNSI

INQUIRY TO SUSPENSION E-MAILED

09/05/2019

CNSI

SUSPENSION INQUIRY WRITTEN

09/05/2019

GNS3

NOTIFICATION OF LETTER OF SUSPENSION E-MAILED

03/05/2019

GNSL

LETTER OF SUSPENSION E-MAILED

03/05/2019

CNSL

SUSPENSION LETTER WRITTEN

03/05/2019

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/26/2019

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/25/2019

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/25/2019

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

09/01/2018

GNRT

NON-FINAL ACTION E-MAILED

09/01/2018

CNRT

NON-FINAL ACTION WRITTEN

09/01/2018

DOCK

ASSIGNED TO EXAMINER

08/30/2018

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

08/09/2018

NWAP

NEW APPLICATION ENTERED

08/07/2018

Continuous trademark protection

Get notified about every new filing that threatens TOMORROW IS GROWN HERE or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.